3. Johnson & Johnson: Cerenovus clot removal products
Johnson & Johnson’s Cerenovus launched three new clot removal products in September 2020. The three devices are designed to help physicians perform mechanical thrombectomy procedures.
The three devices include the Cerebase DA guide sheath, Cerenovus large-bore catheter and Embotrap III revascularization device.
Cerebase DA guide sheath is a long guide sheath that is designed with more trackability trackability to allow physicians to navigate challenging anatomy and secure distal access for geometric anchoring.
The Cerenovus large bore catheter is designed for atraumatic vessel wall interaction to balance trackability with more durability and compatibility. It has distal kink resistance in a thin wall design and allows for rapid navigation to the middle cerebral artery based on anatomically optimized design, according to the company.
Johnson & Johnson describes its Embotrap III revascularization device as a stent retriever designed to engage a range of clot types and provide more tailored options to achieve the first-pass effect, which is an independent predictor of good functional outcome and can result in faster patient recovery times. It is indicated for vessels from 5 mm to 1.5 mm and has a dual-layer design to engage and grip the clot differently. It has been shown to retrieve different thrombus types, including fibrin-rich and RBC-rich clots, according to J&J.
